Abstract
To elucidate the relationship between the frequency of core mutations and precore mutation of hepatitis B virus (HBV) in Japanese HBV carriers, we investigated the nucleotide sequence of the precore/core region of HBV in 26 Japanese HBV carriers [15 who were HBe antigen-negative (HBeAg−) and 11 who were HBeAg-positive (HBeAg+)]. The number of amino acid changes (5.9±3.8) in the core region of HBV in HBeAg-carriers was significantly greater than that in the HBeAg+ carriers (1.5±1.0;P<0.005). The precore stop codon mutation was found in 93.3% of HBeAg-negative HBV carriers, while no precore mutation was found in the HBeAg-positive HBV carriers, suggesting that the frequency of core mutations may be associated with the presence of the precore stop codon mutation. However, there was no significant difference in the frequency of amino acid changes among HBeAg-HBV carriers. The mean number of core amino acid changes of liver cirrhosis patients, chronic active hepatitis patients, chronic persistent hepatitis patients, and asymptomatic carriers were 2.7±1.5, 6.0±2.2, 4.7±1.2, and 8.4±5.3, respectively. We detected hot spots for core mutations, which showed characteristic localizations and specific substitutions: Gly-87, Leu-97, and Thr-130 were detected exclusively in patients with chronic liver disease with or without HBeAg. To address further the relationship between frequency of core mutations and the presence of the precore stop codon mutation, we investigated the precore/core nucleotide sequence serially along with seroconversion in three patients with chronic hepatitis B in whom the hepatitis either became inactive or remained active after the seroconversion. Emergence of the precore stop codon mutation and a significant increase in core amino acid changes after seroconversion were noted in all three patients. Our results suggest a close association between the frequency of core amino acid changes and the presence of the precore stop codon mutation; some characteristic core mutations may be associated with the clinical course of chronic hepatitis B in Japanese patients.
Similar content being viewed by others
References
Thomas HC, Carman WF. The emergence of envelope and precore/core variants of hepatitis B virus: The potential role of antibody selection. J Hepatol 1995;22(Suppl 1):1–8.
Milich DR. Immune response to hepatitis B virus protein. Relevance of murine model. Semin Liver Dis 1991;11:93–112.
Tsai SL, Chen PJ, Lai MY, et al. Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. J Clin Invest 1992;89:87–96.
Bertoletti A, Sette A, Chisari FV, et al. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature 1994;369:407–410.
Mondelli M, Vergani GM, Alberti A, et al. Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes. J Immunol 1982; 129:2773–2778.
Carman WF, Thomas HC. Implications of genetic variation on the pathogenesis of hepatitis B virus infection. Arch Virol 1993; (Suppl)8:143–154.
Bonino F, Brunetto MR. Hepatitis B virus heterogeneity, one of many factors influencing the severity of hepatitis B. J Hepatol 1993;18:5–8.
Omata M, Ehata T, Yokosuka O, et al. Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis. N Engl J Med 1991;324:1699–1704.
Tiollais P, Pourcel C, Dejean A. The hepatitis B virus. 1985; Nature 348:489–495.
Ehata T, Omata M, Yokosuka O, et al. Variations in codons 84–101 in the core nucleotide sequence correlate with hepatocellular injury in chronic hepatitis B virus infection. J Clin Invest 1992;89:332–338.
Ehata T, Omata M, Chuang WL, et al. Mutations in core nucleotide sequence of hepatitis B virus correlate with fulminant and severe hepatitis. J Clin Invest 1993;91:1206–1213.
Wakita T, Kakumu S, Shibata M, et al. Detection of pre-C and core region mutants of hepatitis B virus in chronic hepatitis B carriers. J Clin Invest 1991;88:1793–1801.
Ogata N, Miller R, Ishak K, et al. Complete nucleotide sequence of a pre-core mutant of hepatitis B virus implicated in fulminant hepatitis and its biological characterization in chimpanzees. Virology 1993;194:263–276.
Nakayama J, Nakanishi T, Arataki K, et al. Changes in hepatitis B virus precore and core regions in association with the disappearance of hepatitis B e antigen in patients with chronic hepatitis B. Intern Med 1995;34:319–325.
Kobayashi M, Koike K. Complete nucleotide sequence of hepatitis B virus DNA of subtype adr and its conserved gene organization. Gene 1984;30:227–232.
Ono Y, Onda H, Sasada R, et al. The complete nucleotide sequences of the cloned hepatitis B virus DNA; subtype adr and adw. Nucl Acid Res 1983;11:1747–1757.
Okamoto H, Tsuda F, Sakugawa H, et al. Typing hepatitis B virus by homology in nucleotide sequence: Comparison of surface antigen subtypes. J Gen Virol 1988;69:2575–2583.
Fujiyama A, Miyanohara A, Nozaki C, et al. Cloning and structural analyses of hepatitis B virus DNAs, subtype adr. Nucl Acid Res 1983;11:4601–4610.
Valenzuela P, Quiroga M, Zardivar J, et al. The nucleotide sequence of the hepatitis B virus genome and the identification of the major viral genes. In: Fields B, Jaenish RT, Fox C, editors. Animal virus genetics. New York: Academic, 1980:57–70.
Akarca US, Lok ASF. Naturally occurring hepatitis B virus core gene mutations. Hepatology 1995;22:50–60.
Rodriguez-Frias F, Buti M, Jardi R, et al. Hepatitis B virus infection: Precore mutants and their relation to viral genotypes and core mutations. Hepatology 1995;22:1641–1647.
Karasawa T, Aizawa Y, Zeniya M, et al. Genetic heterogeneity in the precore region of hepatitis B virus in HBeAg-negative chronic hepatitis B patients: Spontaneous seroconversion and interferoninduced seroconversion. J Med Virol 1995;45:373–380.
Okamoto H, Yotsumoto S, Akahane Y, et al. Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen. J Virol 1990;64:1298–1303.
Carman WF, Jacyna MR, Handziyannis S, et al. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet 1989;9:588–591.
Hamasaki T, Nakata K, Daikoku S, et al. Changes in the prevalence of HBeAg-negative mutant hepatitis B virus during the course of chronic hepatitis B. Hepatology 1994;20:8–14.
Pollicino T, Campo S, Raimondo G, et al. PreS and core gene heterogeneity in HBV genomes isolated from patients with longlasting HBV infection. Virology 1993;208:672–677.
Ferrari C, Bertoletti A, Penna A, et al. Identification of immunodominant T-cell epitopes of the hepatitis B virus nucleocapsid antigen. J Clin Invest 1991;88:214–222.
Salfeld J, Pfaff E, Noah M, et al. Antigenic determinants and functional domains in core antigen and e antigen from hepatitis B virus. J Virol 1989;63:798–808.
Tordjeman M, Fontan G, Rabillon V, et al. Characterization of minor and major antigenic regions within the hepatitis B virus nucleocapsid. J Med Virol 1993;41:221–229.
Hatton T, Zhou S, Standring DN. RNA- and DNA-binding activity in hepatitis B virus capsid protein: A model for their roles in viral replication. J Virol 1992;66:5232–5241.
Junker-Niepmann M, Bartenschlager R, Schaller H. A short cisacting sequence is required for hepatitis B virus pregenome encapsidation and sufficient for packaging of foreign RNA. EMBO J 1990;9:3389–3396.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Karasawa, T., Shirasawa, T., Okawa, Y. et al. Association between frequency of amino acid changes in core region of hepatitis B virus (HBV) and the presence of precore mutation in Japanese HBV carriers. J Gastroenterol 32, 611–622 (1997). https://doi.org/10.1007/BF02934110
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02934110